These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25228365)

  • 101. A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B.
    Wakata K; Tsuchiya T; Tomoshige K; Takagi K; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Whitsett JA; Maeda Y; Nagayasu T
    BMJ Open; 2015 Jul; 5(7):e008366. PubMed ID: 26224019
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Utilisation and Determinants of Epidermal Growth Factor Receptor Mutation Testing in Patients with Non-small Cell Lung Cancer in Routine Clinical Practice: A Global Systematic Review.
    Thi AM; Tin Tin S; McKeage M; Elwood JM
    Target Oncol; 2020 Jun; 15(3):279-299. PubMed ID: 32445082
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Compound Uncommon EGFR Mutations in a Patient with Advanced NSCLC and Durable Response to Sequential EGFR Targeted Therapies.
    Peters MLB; Costa DB; Rangachari D
    J Thorac Oncol; 2017 Apr; 12(4):e35-e36. PubMed ID: 28343545
    [No Abstract]   [Full Text] [Related]  

  • 104. Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.
    Siegele BJ; Shilo K; Chao BH; Carbone DP; Zhao W; Ioffe O; Franklin WA; Edelman MJ; Aisner DL
    Lung Cancer; 2016 May; 95():65-72. PubMed ID: 27040854
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Proton Irradiation Sensitizes Radioresistant Non-small Cell Lung Cancer Cells by Modulating Epidermal Growth Factor Receptor-mediated DNA Repair.
    Park HJ; Oh JS; Chang JW; Hwang SG; Kim JS
    Anticancer Res; 2016 Jan; 36(1):205-12. PubMed ID: 26722045
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Correlation between epidermal growth factor receptor (EGFR) intron1 (CA) n microsatellite polymorphism, lymph node metastasis and expression of EGFR in non-small cell lung cancer].
    Zhao L; Jiang X; Peng F; Zhou R
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):476-7. PubMed ID: 21055178
    [No Abstract]   [Full Text] [Related]  

  • 107. Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
    Kim JS; Cho MS; Nam JH; Kim HJ; Choi KW; Ryu JS
    PLoS One; 2017; 12(5):e0177015. PubMed ID: 28486527
    [TBL] [Abstract][Full Text] [Related]  

  • 108. In silico analysis of the effect of mutation on epidermal growth factor receptor in non-small-cell lung carcinoma: from mutational analysis to drug designing.
    Zhao FL; Yang GH; Xiang S; Gao DD; Zeng C
    J Biomol Struct Dyn; 2017 Feb; 35(2):427-434. PubMed ID: 26813338
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.
    Liu X; Wang P; Zhang C; Ma Z
    Oncotarget; 2017 Jul; 8(30):50209-50220. PubMed ID: 28430586
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Clinicopathological features associated with EGFR gene mutation in non-small cell lung cancer patients].
    Zhou J; Mo W; Zhao J; Zheng J; Ding W; Zhou J
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(30):2332-6. PubMed ID: 25399972
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.
    Li SD; Ma M; Li H; Waluszko A; Sidorenko T; Schadt EE; Zhang DY; Chen R; Ye F
    Genome Med; 2017 Oct; 9(1):89. PubMed ID: 29082853
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [Consensus for epidermal growth factor receptor gene mutation detection in non-small cell lung cancer].
    Consensus Group for Epidermal Growth Factor Receptor Gene Mutation Detection in Non-Small Cell Lung Cancer
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):700-2. PubMed ID: 22321552
    [No Abstract]   [Full Text] [Related]  

  • 113. A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.
    Moran T; Quiroga V; Cirauqui B; Vila L; Gil-Moreno M; Carcereny E; Margeli M; Muñoz-Marmol A; Mate JL; Velarde JM; Molina MA; Rosell R
    Oncol Res Treat; 2019; 42(3):107-114. PubMed ID: 30799393
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases.
    Ponce S; Bruna J; Juan O; López R; Navarro A; Ortega AL; Puente J; Verger E; Bartolomé A; Nadal E
    Crit Rev Oncol Hematol; 2019 Jun; 138():190-206. PubMed ID: 31092376
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients.
    Kota R; Gundeti S; Gullipalli M; Linga VG; Maddali LS; Digumarti R
    Lung India; 2015; 32(6):561-5. PubMed ID: 26664160
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.
    Isla D; Felip E; Viñolas N; Provencio M; Majem M; Artal A; Bover I; Lianes P; DE Las Peñas R; Catot S; DE Castro J; Blasco A; Terrasa J; Gonzalez-Larriba JL; Juan O; Dómine M; Bernabe R; Garrido P
    Anticancer Res; 2016 Dec; 36(12):6647-6653. PubMed ID: 27919997
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Epidermal Growth Factor Receptor Activating Mutations in Squamous Histology of Lung Cancer Patients of Southern Bulgaria.
    Genova SN; Bichev SN; Kanarev VG
    Folia Med (Plovdiv); 2015; 57(3-4):191-9. PubMed ID: 27180345
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.
    Lee JW; Soung YH; Kim SY; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Int J Cancer; 2005 Jan; 113(3):510-1. PubMed ID: 15455340
    [No Abstract]   [Full Text] [Related]  

  • 119. [Exploring the Possibility of New Biomarkers of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer (NSCLC)].
    Owada Y; Inoue T; Watanabe Y; Fukuhara M; Yamaura T; Muto S; Matsumura Y; Hasegawa T; Tanaka D; Kanno R; Ito E; Nanamiya H; Imai J; Isogai T; Watanabe S; Suzuki H
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):763-766. PubMed ID: 28912405
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Sharpening the attack on non-small cell lung cancer.
    Alexander A; Quincy B
    JAAPA; 2016 Nov; 29(11):1-5. PubMed ID: 27787282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.